Apolipoprotein ε4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty
- 1 June 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (16) , 1181-1183
- https://doi.org/10.1016/s0002-9149(99)80756-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Genetic Dissection of Complex TraitsScience, 1994
- Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.Circulation, 1994
- ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery diseaseThe American Journal of Cardiology, 1993
- Apolipoprotein ∈4 homozygosity in young men with coronary heart diseaseThe Lancet, 1992
- Relation of plasma lipid and apoprotein levels to progressive intimal hyperplasia after arterial endarterectomy.Circulation, 1992
- Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988